Valerie Daggett is the founder and CEO of AltPep and a professor of Bioengineering at the University of Washington. She has over 250 peer-reviewed publications and is a fellow of the American Institute of Medical and Biological Engineering and The Biophysical Society. AltPep is a recent spinout from her UW lab focused on early diagnostics and disease-modifying therapeutics for Alzheimer’s Disease targeting a novel protein structure discovered in her lab.